BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 28627030)

  • 41. MiR-338 suppresses the growth and metastasis of OSCC cells by targeting NRP1.
    Liu C; Wang Z; Wang Y; Gu W
    Mol Cell Biochem; 2015 Jan; 398(1-2):115-22. PubMed ID: 25204970
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1.
    Chen L; Zhu Q; Lu L; Liu Y
    Bioengineered; 2020 Dec; 11(1):91-102. PubMed ID: 31906769
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overexpression of miR-155 promotes the proliferation and invasion of oral squamous carcinoma cells by regulating BCL6/cyclin D2.
    Zeng Q; Tao X; Huang F; Wu T; Wang J; Jiang X; Kuang Z; Cheng B
    Int J Mol Med; 2016 May; 37(5):1274-80. PubMed ID: 26986233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MiR-101-3p Regulates the Viability of Lung Squamous Carcinoma Cells via Targeting EZH2.
    Hou Y; Li L; Ju Y; Lu Y; Chang L; Xiang X
    J Cell Biochem; 2017 Oct; 118(10):3142-3149. PubMed ID: 27966775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MiR-590-5p regulates cell proliferation, apoptosis, migration and invasion in oral squamous cell carcinoma by targeting RECK.
    Bao WW; Shi YL; Ma Y; Qu XH; Pang GM; Yang L
    Histol Histopathol; 2021 Mar; 36(3):355-365. PubMed ID: 33447989
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Downregulation of miR-377 Promotes Oral Squamous Cell Carcinoma Growth and Migration by Targeting HDAC9.
    Rastogi B; Kumar A; Raut SK; Panda NK; Rattan V; Joshi N; Khullar M
    Cancer Invest; 2017 Mar; 35(3):152-162. PubMed ID: 28267394
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LncRNA BLACAT1 regulates the viability, migration and invasion of oral squamous cell carcinoma cells by targeting miR-142-5p.
    Dai D; Feng XD; Zhu WQ; Bao YN
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10313-10323. PubMed ID: 31841186
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MiR-1254 Functions as a Tumor Suppressor in Oral Squamous Cell Carcinoma by Targeting CD36.
    Chen R; Zhang Y; Zhang X
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819859447. PubMed ID: 31401948
    [TBL] [Abstract][Full Text] [Related]  

  • 49.
    Tang KL; Tang HY; Du Y; Tian T; Xiong SJ
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3278-3285. PubMed ID: 31379206
    [No Abstract]   [Full Text] [Related]  

  • 50. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
    Xu L; Hou TJ; Yang P
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HPV 16 E7 inhibits OSCC cell proliferation, invasion, and metastasis by upregulating the expression of miR-20a.
    Hu J; Ge W; Xu J
    Tumour Biol; 2016 Jul; 37(7):9433-40. PubMed ID: 26781875
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MiR-139-5p/SLC7A11 inhibits the proliferation, invasion and metastasis of pancreatic carcinoma via PI3K/Akt signaling pathway.
    Zhu JH; De Mello RA; Yan QL; Wang JW; Chen Y; Ye QH; Wang ZJ; Tang HJ; Huang T
    Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165747. PubMed ID: 32109492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. miR-454 performs tumor-promoting effects in oral squamous cell carcinoma via reducing NR3C2.
    Guo JY; Wang YK; Lv B; Jin H
    J Oral Pathol Med; 2020 Apr; 49(4):286-293. PubMed ID: 32170966
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression and mechanism of long non-coding RNA HCG22 in oral squamous cell carcinoma.
    Gao YQ; Shi PW; Shi WK; Liu YM
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Dec; 39(6):658-666. PubMed ID: 34859625
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA-22 suppresses cell proliferation, migration and invasion in oral squamous cell carcinoma by targeting NLRP3.
    Feng X; Luo Q; Wang H; Zhang H; Chen F
    J Cell Physiol; 2018 Sep; 233(9):6705-6713. PubMed ID: 29319163
    [TBL] [Abstract][Full Text] [Related]  

  • 56. circBICD2 targets miR-149-5p/IGF2BP1 axis to regulate oral squamous cell carcinoma progression.
    Qiu L; Zheng L; Gan C; Deng W; Sun Y; Wang T
    J Oral Pathol Med; 2021 Aug; 50(7):668-680. PubMed ID: 33382158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circ_0001971 regulates oral squamous cell carcinoma progression and chemosensitivity by targeting miR-194/miR-204 in vitro and in vivo.
    Tan X; Zhou C; Liang Y; Lai YF; Liang Y
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2470-2481. PubMed ID: 32196598
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-92b promotes tumor growth and activation of NF-κB signaling via regulation of NLK in oral squamous cell carcinoma.
    Liu Z; Diep C; Mao T; Huang L; Merrill R; Zhang Z; Peng Y
    Oncol Rep; 2015 Dec; 34(6):2961-8. PubMed ID: 26503628
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MiR-126 inhibits cell migration and invasion by targeting ADAM9 in oral squamous cell carcinoma.
    Qin WJ; Lv LH; Zhang M; Zhou X; Liu GQ; Lu HJ
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10324-10331. PubMed ID: 31841187
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LncRNA, TUG1 regulates the oral squamous cell carcinoma progression possibly via interacting with Wnt/β-catenin signaling.
    Liang S; Zhang S; Wang P; Yang C; Shang C; Yang J; Wang J
    Gene; 2017 Apr; 608():49-57. PubMed ID: 28119088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.